Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

3.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.0K
Production of Formed Elements01:34

Production of Formed Elements

3.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
3.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

8.4K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.4K
Hematopoiesis01:21

Hematopoiesis

8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.8K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

3.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Blood·2026
Same author

CD24 senescent neutrophils as key players in myelofibrosis.

Blood·2025
Same author

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nature communications·2025
Same author

Progressive chromatin rewiring by ETO2::GLIS2 revealed in a genome-edited human iPSC model of pediatric leukemia initiation.

Blood·2024
Same author

Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.

Blood·2024
Same author

DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.

EMBO molecular medicine·2024

Related Experiment Video

Updated: Jan 19, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.4K

Megakaryocyte polyploidization: role in platelet production.

William Vainchenker1, Hana Raslova1

  • 1UMR 1170, Institut National de la Santé et de la Recherche Médicale, Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy Cancer Campus, Equipe Labellisée Ligue Nationale Contre le Cancer , Villejuif, France.

Platelets
|September 24, 2019
PubMed
Summary

Mammal megakaryocytes (MKs) increase in size through polyploidization, a process crucial for economical platelet production. This process is regulated by external factors and transcription factors, and is altered in certain blood disorders.

Keywords:
Endomitosismegakaryocytepolyploidization

More Related Videos

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

7.5K
Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 19, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.4K
Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

7.5K
Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.5K

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Mammalian megakaryocytes (MKs) are large cells responsible for platelet production.
  • MK polyploidization, an increase in DNA content without cell division, is essential for generating sufficient platelet mass.
  • This process involves endoreduplication, resulting in giant cells with polyploid nuclei.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of megakaryocyte polyploidization during development and disease.
  • To explore the interplay between polyploidization, organelle development, and platelet production.
  • To understand the alterations in MK polyploidization in malignant myeloid disorders and hereditary thrombocytopenia.

Main Methods:

  • Review of existing literature on megakaryocyte differentiation and polyploidization.
  • Analysis of the roles of extrinsic factors like thrombopoietin (TPO).
  • Investigation of intrinsic regulatory factors including transcription factors (RUNX1, GATA1, FLI1).

Main Results:

  • Polyploidization increases MK size and cytoplasm, enabling economical platelet production.
  • Parallel development of MK organelles is required for effective platelet generation.
  • MK polyploidization is tightly regulated by TPO and key transcription factors, with alterations observed in various hematological disorders.

Conclusions:

  • Megakaryocyte polyploidization is a complex, regulated process vital for platelet homeostasis.
  • Dysregulation of polyploidization contributes to pathological conditions like leukemia and thrombocytopenia.
  • Enhancing MK polyploidization *in vitro* remains a challenge for improving platelet yields.